A study to confirm the effect of research food intake on improving immune function - Randomized, double-blind, parallel-group comparison method
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000048938
- Lead Sponsor
- KSO Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 75
Not provided
Subjects - - 1. scheduled to be vaccinated for 3 weeks prior to each examination. 2. suffering from diabetes, renal or hepatic disease or other serious diseases, or metabolic diseases, autoimmune diseases, undergoing treatment, or with a history of such diseases. 3. with chronic illnesses who take pharmaceuticals on a daily basis. 4. who regularly use medicines that may affect immunity, foods for specified health uses, etc, and who are unable to stop taking them during the study period. 5. who are unable to stop taking Lactobacillus and Bifidobacteria-rich foods during the study period. 6. who have taken antibiotics for 1 month prior to the screening test. 7. who constantly consumes alcohol in excess of the appropriate amount. 8. who are unable to abstain from alcohol for 2 days prior to each test. 9. with declared food allergies. 10. with a history or current history of hay fever. 11. with atopic dermatitis, allergic rhinitis, bronchial asthma, or chronic bronchitis. 12. who work day and night shifts. 13. who work full-time telecommuters. 14. who have dental or oral problems that involve bleeding, or plan to undergo dental or oral treatment. 15. who have a habit of jogging or other strenuous exercise. 16. who smoke. 17. with gastrointestinal diseases and absorption and a history of gastrointestinal surgery (except appendicitis). 18. who a pregnant, intending to become pregnant during the study period, or breastfeeding. 19. with a history or current history of drug or alcohol dependence. 20. who are currently participating in research involving the ingestion of other foods or the use of pharmaceuticals, or who intend to participate in such research. 21. who have donated more than 200 mL of blood or component blood within 1 month or 400 mL within 3 months prior to the date consent was obtained. 22. who deemed inappropriate as research subjects by the principal investigator--.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method